Heart Failure

Chemists have uncovered a new technique that could make it possible to heal a patient’s damaged heart tissue after a myocardial infarction (MI).

Trabeculae, detailed networks of muscle fibers on the heart, were first sketched by Leonardo da Vinci 500 years ago. He wondered what they were and what, exactly, they did.

COVID-19 enters a person’s heart cells by attacking certain proteins—and when more of those proteins are present, the virus has more chances to cause damage.

The proposed changes, announced August 12, are focused on easing a variety of requirements.

The study's authors explored data from 870 acute heart failure patients treated at the same facility from January 2012 to December 2017.

The study, published in Circulation: Arrhythmia and Electrophysiology, included data from more than 1,600 patients who presented at the ED with shortness of breath. 

As the COVID-19 pandemic continues, researchers have been forced to put important projects on hold—and it’s unclear when things will return to normal.

The original software first received FDA clearance back in 2018. This updated version, Caption Health has said, is easier for clinicians to use. 

Such testing typically makes the most sense when patients have a confirmed diagnosis of an inherited cardiovascular disease or an abnormality has already been identified.

A new commentary in Circulation: Heart Failure offers a first-hand account of how one facility embraced telehealth and faced the pandemic head-on.

Stress cardiomyopathy—often referred to as broken heart syndrome—was up significantly in March and April 2020.

preCARDIA announced that its catheter-based system for acutely decompensated heart failure has received the FDA’s breakthrough device designation.